Comprehensive cost and utilization of commercial CAR-T therapy in pediatric B-ALL patients

Leukemia News

Comprehensive cost and utilization of commercial CAR-T therapy in pediatric B-ALL patients
CancerCellChildren
  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 73 sec. here
  • 9 min. at publisher
  • 📊 Quality Score:
  • News: 53%
  • Publisher: 71%

A new editorial paper was published in Oncoscience (Volume 11) on April 25, 2024, entitled, 'The price of hope: CAR-T therapy in pediatric leukemia.'

May 17 2024Oncoscience A new editorial paper was published in Oncoscience on April 25, 2024, entitled, "The price of hope: CAR-T therapy in pediatric leukemia."

We stand at the crossroads of medical innovation, where cutting-edge scientific discoveries intersect with the resilience of the human body, providing hope to families grappling with a diagnosis of pediatric leukemia.

Following the pivotal ELIANA trial, tisa-cel was approved in the United States for the treatment of refractory or second or greater relapse of B-ALL in patients under age 25. This innovative therapy involves genetically modifying a patient's native T-cells – immune cells with the ability to kill and/or regulate infected or diseased cells – to express a receptor that targets cancer cells.

Upon its approval in 2017, Novartis priced tisa-cel at $475,000 – a number that many healthcare systems and payers balked at initially – and in 2023 the price increased to $508,250. However, compared to more recently approved ex vivo gene therapies such as bluebird bio's Zynteglo for beta thalassemia priced at $2.8 million or Vertex Pharmaceuticals' Casgevy for sickle cell disease at $2.2 million, the half-million dollar tisa-cel price tag is less staggering.

"Our team recently published an in-depth analysis of the comprehensive cost and utilization of commercial CAR-T therapy in pediatric B-ALL patients with commercial insurance in the United StatesJournal reference:Hoover, A. . The price of hope: CAR-T therapy in pediatric leukemia. Oncoscience. doi.org/10.18632/oncoscience.598.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

NewsMedical /  🏆 19. in UK

Cancer Cell Children Healthcare Receptor Research

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

NI woman’s warning to holidaymakers as car 'stolen' from airport car parkNI woman’s warning to holidaymakers as car 'stolen' from airport car parkThe incident is being investigated by the Gardaí and airport police
Read more »

Fire crews rush to street in early hours after car goes up in flamesFire crews rush to street in early hours after car goes up in flamesThe blaze broke out while the car was parked in a car park
Read more »

Witness appeal after beauty cases stolen from car at Calderglen Country ParkWitness appeal after beauty cases stolen from car at Calderglen Country ParkHandbags and beauty cases were reportedly stolen from a car parked in the main car park
Read more »

Amazon Auto car accessory that 'adds Alexa to your car' now £30 off in saleAmazon Auto car accessory that 'adds Alexa to your car' now £30 off in saleYou can also use just your voice to make calls, reply to a text and drop in on Alexa-enabled devices in your home.
Read more »

DWP minister issues PIP update on 'comprehensive' assessment criteriaDWP minister issues PIP update on 'comprehensive' assessment criteriaThe DWP Minister has given an update on PIP assessments after a question from an SNP MP
Read more »

The comprehensive guide to Indy 500: Huge prize money, big race traditions and formats explainedOne of the biggest races in the world is upon us and here is everything you need to know.
Read more »



Render Time: 2025-02-22 12:18:49